Platform · Alerts

Never miss a regulatory change that affects your products

Alerts monitors international and national regulatory authorities around the clock, flags the guidance changes that apply to your product classes, and tells you what each one means in the markets where you sell.

Inside Alerts

Regulatory change, mapped to your portfolio

Every relevant update across authorities, tied to the products it affects. Explore the live workspace below.

Alerts
Subscribed jurisdictionsAuto-triaged for owned portfolios
9
Needs reviewCritical and high severity
14
Total in feedAcross subscribed jurisdictions
34
Global Regulatory Alert Map
All regions
+Reset250%
Brazil2 jurisdiction alerts · Subscribed
Subscribed
2
BrazilANVISA · Submission window opens 15 May
High×
ANVISA introduces accelerated pathway for biosimilars
RDC 612/2026 establishes an abbreviated registration route for biosimilars previously authorized by EMA, FDA, MHRA, or PMDA, reducing local clinical data requirements.
Impact: 2 EU-approved biosimilars in your portfolio qualify. Estimated 12–18 months saved per filing.
Build registration strategy for tocilizumab biosimilar — check pathway eligibility and parallel LATAM filings.
BiosimilarsRegistration pathway
LATAM Regulatory Lead3 d ago
Strategy review recommended within 30 days
Highest urgency
Critical
High
Medium
Low
EMANational agenciesGuidelines & Q&AsTemplatesMapped to your MAsLocalized impact
The problem

Nobody can read every authority's updates by hand

Guidance changes land across dozens of EMA and national-agency sources, in different formats and languages. Reading all of it is unrealistic; skimming it means missing the one update that affects your product. By the time a change surfaces internally, the deadline to act on it may already be close.

How it works

From the firehose to what actually affects you

1

We monitor every source

International and national authorities are tracked continuously: guidelines, Q&As, templates and procedural changes, as they're published.

2

We map it to your portfolio

Each change is matched against your products, classes and markets, so you only see what applies to you.

3

You get the impact and the action

A clear read on what changed, which of your MAs it touches and what to do next, ready to hand off into the work.

What you get

Signal, mapped to your products

Broad source coverage

EMA and national authorities monitored together, so no relevant change slips through a gap between sources.

Portfolio mapping

Every change tied to the specific products, classes and markets it affects, rather than a generic industry digest.

Localized impact

What a change means in each market, in plain terms, so you can judge urgency at a glance.

Straight into action

Hand a change off to obligation-to-action and Workbench to turn it into a product-specific to-do list.

Why Regunaut

The monitoring is done for you, mapped to your portfolio

Filtered against your portfolio

Everything that reaches you has already been matched to your products, so it's worth your attention.

Nothing slips

Continuous coverage across authorities means changes are caught early, with time to act.

Connected to the work

Alerts feeds Atlas and Workbench, so spotting a change and acting on it aren't separate tasks.

Regulatory monitoring that used to need a department — run by a team of a few.

See only the changes that matter to you

Book a demo and watch Alerts map regulatory change to your own products and markets.

Book a 30-min walkthrough